Day 0 (N, % and 95 CI) | Day 2 (N, % and 95 CI) | Day 3 (N, % and 95 CI) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Group | SIT test | CIT Test | IGRA | P22 ELISA | SIT Test | CIT test | SIT test | CIT test | IGRA | P22 ELISA |
Corticosteroids (n = 53) | NA | NA | 22, 41.5% (29.3–54.9) | 21, 39.6% (27.6–53.1) | 34, 64.2% (50.7–75.7) | 10, 18.9% (10.6–31.4) | 23, 43.4% (31–56.7) | 10, 18.9% (10.6–31.4) | 35, 66% (52.6–77.3) | 23, 43.4% (30.9–56.7) |
Pre-sensitized (n = 48) | 39, 81.3% (68.1–89.8) | 22, 45.8% (32.6–59.7) | 37, 77.1% (63.5–86.7) | 25, 52.1% (38.3–65.5) | NA | NA | 41a, 85.4% (72.8–92.8) | 22a, 45.8% (32.6–59.7) | 31, 65.6% (50.4–76.6) | 25, 52.1% (38.3–65.5) |
Control (n = 50) | NA | NA | 28, 56% (42.3–68.8) | 17, 34% (22.4–47.9) | NA | NA | 32, 64% (50.1–75.9) | 13, 26% (15.9–39.6) | 36, 72% (58.3–82.5) | 21, 42% (29.4–55.7) |